trial

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

NCTId NCT05958875
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Recruiting
Enrollment 418 (estimated)
Sponsored by Dr. Inge Winter
Primary completion 2028-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Recruiting
Enrollment
418 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2024-08-01
Primary completion
2028-06-30
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
Clozapine

Sponsors

Dr. Inge WinterLead Sponsor
Universität MünsterCollaborator

Sites

13 total
Innsbruck, AustriaAugsburg, GermanyBielefeld, GermanyDortmund, GermanyFrankfurt am Main, GermanyMainz, GermanyMünster, GermanyBrescia, ItalyCagliari, ItalyNaples, ItalyTurin, ItalyBarcelona, Spain

Facts & assertions

4 sourced
Enrollment
418
Phase
PHASE4
Primary Completion Date
2028-06-30
Status
RECRUITING
relationships
The graph out of here
drug
Clozapine
drug
lead_sponsor
Dr. Inge Winter
company
collaborator
Universität Münster
company
indication
Schizophrenia and Related Disorders
indication
Early Treatment-Resistance
indication
Schizophrenia
indication